StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics cash

Cash and short-term investments held at the end of each period.

TFA Therapeutics's cash was $3.20K at Dec 31, 2025. For fiscal 2025 it was $3.20K, down 91.4% from the year before. The highest annual figure on record is $99.49K in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.20K-91.4%
FY2024Dec 31, 2024$37.28K+61.4%
FY2023Dec 31, 2023$23.10K+248.6%
FY2022Dec 31, 2022$6.63K-93.3%
FY2021Dec 31, 2021$99.49K+33739.1%
FY2020Dec 31, 2020$294–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$3.20K-51.7%
Q4 FY2024Dec 31, 2024$37.28K+92.8%
Q4 FY2023Dec 31, 2023$23.10K-76.8%
Q3 FY2023Sep 30, 2023$16.91K+5652.0%
Q4 FY2022Dec 31, 2022$6.63K–
Q3 FY2022Sep 30, 2022$19.34K–
Q4 FY2021Dec 31, 2021$99.49K–
Q4 FY2020Dec 31, 2020$294–

More TFA Therapeutics figures

See a number that looks wrong?